Clínica Baviera, S.A.

BATS-CHIXE:CBAVE Stock Report

Market Cap: €494.0m

Clínica Baviera Past Earnings Performance

Past criteria checks 5/6

Clínica Baviera has been growing earnings at an average annual rate of 24.4%, while the Healthcare industry saw earnings growing at 11.2% annually. Revenues have been growing at an average rate of 16.5% per year. Clínica Baviera's return on equity is 48.5%, and it has net margins of 15.8%.

Key information

24.4%

Earnings growth rate

22.8%

EPS growth rate

Healthcare Industry Growth12.6%
Revenue growth rate16.5%
Return on equity48.5%
Net Margin15.8%
Last Earnings Update30 Jun 2024

Recent past performance updates

No updates

Recent updates

No updates

Revenue & Expenses Breakdown

How Clínica Baviera makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BATS-CHIXE:CBAVE Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 2424338120
31 Mar 2423537120
31 Dec 2322736120
30 Sep 232173200
30 Jun 2321231120
31 Mar 2320429120
31 Dec 2219830120
30 Sep 2219330100
30 Jun 2218930100
31 Mar 2218431100
31 Dec 2117327100
30 Sep 211652880
30 Jun 211602780
31 Mar 211342080
31 Dec 201231480
30 Sep 201171290
30 Jun 20112990
31 Mar 201241100
31 Dec 191241390
30 Sep 1911912150
30 Jun 1911512150
31 Mar 1911012150
31 Dec 1810912150
30 Sep 1810711150
30 Jun 1810612150
31 Mar 1810411150
31 Dec 1710010150
30 Sep 17978130
30 Jun 17948130
31 Mar 17928130
31 Dec 16928130
30 Sep 16929130
30 Jun 16918130
31 Mar 16886130
31 Dec 15865130
30 Sep 15844130
30 Jun 15834130
31 Mar 15833130
31 Dec 14834130
30 Sep 14803120
30 Jun 14793120
31 Mar 14805120
31 Dec 13805120
30 Sep 13920160

Quality Earnings: CBAVE has high quality earnings.

Growing Profit Margin: CBAVE's current net profit margins (15.8%) are higher than last year (14.8%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: CBAVE's earnings have grown significantly by 24.4% per year over the past 5 years.

Accelerating Growth: CBAVE's earnings growth over the past year (22.5%) is below its 5-year average (24.4% per year).

Earnings vs Industry: CBAVE earnings growth over the past year (22.5%) exceeded the Healthcare industry 13.6%.


Return on Equity

High ROE: CBAVE's Return on Equity (48.5%) is considered outstanding.


Return on Assets


Return on Capital Employed


Discover strong past performing companies